Botulinum toxins for analgesia.
Smith
Howard S
HS
D000700:Analgesics / Q000494:pharmacology / Q000627:therapeutic use*; D000818:Animals; D019274:Botulinum Toxins, Type A / Q000494:pharmacology / Q000627:therapeutic use*; D002986:Clinical Trials as Topic / Q000706:statistics & numerical data; D004195:Disease Models, Animal; D006801:Humans; D009465:Neuromuscular Agents / Q000494:pharmacology / Q000627:therapeutic use; D009619:Nociceptors / Q000187:drug effects / Q000502:physiology; D010147:Pain Measurement / Q000379:methods; D017060:Patient Satisfaction; D010523:Peripheral Nervous System Diseases / Q000188:drug therapy* / Q000378:metabolism / Q000503:physiopathology; D051381:Rats; D011984:Sensory Receptor Cells / Q000187:drug effects / Q000502:physiology; D009435:Synaptic Transmission / Q000187:drug effects / Q000502:physiology; D013995:Time; D016896:Treatment Outcome
D000700:Analgesics; D009465:Neuromuscular Agents; D019274:Botulinum Toxins, Type A